Cargando…

How to improve hospital admission screening for patients at risk of multidrug-resistant organism carriage: a before-and-after interventional study and cost-effectiveness analysis

BACKGROUND: Infection prevention and control (IPC) is a prioritised task for healthcare workers in emergency department (ED). Here, we examined compliance with admission screening (AS) and additional precautions (AP) measures for patients at risk of infection with multidrug-resistant organisms (MDRO...

Descripción completa

Detalles Bibliográficos
Autores principales: Joubert, Dominique, Cullati, Stephane, Briot, Pascal, Righi, Lorenzo, Grauser, Damien, Ourahmoune, Aimad, Chopard, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052048/
https://www.ncbi.nlm.nih.gov/pubmed/35483731
http://dx.doi.org/10.1136/bmjoq-2021-001699
_version_ 1784696700923805696
author Joubert, Dominique
Cullati, Stephane
Briot, Pascal
Righi, Lorenzo
Grauser, Damien
Ourahmoune, Aimad
Chopard, Pierre
author_facet Joubert, Dominique
Cullati, Stephane
Briot, Pascal
Righi, Lorenzo
Grauser, Damien
Ourahmoune, Aimad
Chopard, Pierre
author_sort Joubert, Dominique
collection PubMed
description BACKGROUND: Infection prevention and control (IPC) is a prioritised task for healthcare workers in emergency department (ED). Here, we examined compliance with admission screening (AS) and additional precautions (AP) measures for patients at risk of infection with multidrug-resistant organisms (MDROs) by using a two-stage, multifaceted educational intervention, also comparing the cost of a developed automated indicator for AS and AP compliance and clinical audits to sustain observed findings. METHODS: In the first stage, staff in the ED of the University Hospitals of Geneva, Switzerland, were briefed on IPC measures (AS and AP). A cross-sectional survey was then conducted to assess barriers to IPC measures. In the second stage, healthcare workers underwent training sessions, and an electronic patient record ‘order-set’ including AS and AP compliance indicators was designed. We compared the cost–benefit of the audits and the automated indicators for AS and AP compliance. RESULTS: Compliance significantly improved after training, from 36.2% (95% CI 23.6% to 48.8%) to 78.8% (95% CI 67.1% to 90.3%) for AS (n=100, p=0.0050) and from 50.2% (95% CI 45.3% to 55.1%) to 68.5% (95% CI 60.1% to 76.9%) for AP (n=125, p=0.0092). Healthcare workers recognised MDRO screening as an ED task (70.2%), with greater acknowledgment of risk factors at AS considered an ED duty. The monthly cost was higher for clinical audits than the automated indicator, with a reported yearly cost of US$120 203. The initial cost of developing the automated indicator was US$18 290 and its return on investment US$3.44 per US$1 invested. CONCLUSION: Training ED staff increased compliance with IPC measures when accompanied by team discussions for optimal effectiveness. An automated indicator of compliance is cheaper and closer to real-time than a clinical audit.
format Online
Article
Text
id pubmed-9052048
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-90520482022-05-12 How to improve hospital admission screening for patients at risk of multidrug-resistant organism carriage: a before-and-after interventional study and cost-effectiveness analysis Joubert, Dominique Cullati, Stephane Briot, Pascal Righi, Lorenzo Grauser, Damien Ourahmoune, Aimad Chopard, Pierre BMJ Open Qual Quality Improvement Report BACKGROUND: Infection prevention and control (IPC) is a prioritised task for healthcare workers in emergency department (ED). Here, we examined compliance with admission screening (AS) and additional precautions (AP) measures for patients at risk of infection with multidrug-resistant organisms (MDROs) by using a two-stage, multifaceted educational intervention, also comparing the cost of a developed automated indicator for AS and AP compliance and clinical audits to sustain observed findings. METHODS: In the first stage, staff in the ED of the University Hospitals of Geneva, Switzerland, were briefed on IPC measures (AS and AP). A cross-sectional survey was then conducted to assess barriers to IPC measures. In the second stage, healthcare workers underwent training sessions, and an electronic patient record ‘order-set’ including AS and AP compliance indicators was designed. We compared the cost–benefit of the audits and the automated indicators for AS and AP compliance. RESULTS: Compliance significantly improved after training, from 36.2% (95% CI 23.6% to 48.8%) to 78.8% (95% CI 67.1% to 90.3%) for AS (n=100, p=0.0050) and from 50.2% (95% CI 45.3% to 55.1%) to 68.5% (95% CI 60.1% to 76.9%) for AP (n=125, p=0.0092). Healthcare workers recognised MDRO screening as an ED task (70.2%), with greater acknowledgment of risk factors at AS considered an ED duty. The monthly cost was higher for clinical audits than the automated indicator, with a reported yearly cost of US$120 203. The initial cost of developing the automated indicator was US$18 290 and its return on investment US$3.44 per US$1 invested. CONCLUSION: Training ED staff increased compliance with IPC measures when accompanied by team discussions for optimal effectiveness. An automated indicator of compliance is cheaper and closer to real-time than a clinical audit. BMJ Publishing Group 2022-04-27 /pmc/articles/PMC9052048/ /pubmed/35483731 http://dx.doi.org/10.1136/bmjoq-2021-001699 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Quality Improvement Report
Joubert, Dominique
Cullati, Stephane
Briot, Pascal
Righi, Lorenzo
Grauser, Damien
Ourahmoune, Aimad
Chopard, Pierre
How to improve hospital admission screening for patients at risk of multidrug-resistant organism carriage: a before-and-after interventional study and cost-effectiveness analysis
title How to improve hospital admission screening for patients at risk of multidrug-resistant organism carriage: a before-and-after interventional study and cost-effectiveness analysis
title_full How to improve hospital admission screening for patients at risk of multidrug-resistant organism carriage: a before-and-after interventional study and cost-effectiveness analysis
title_fullStr How to improve hospital admission screening for patients at risk of multidrug-resistant organism carriage: a before-and-after interventional study and cost-effectiveness analysis
title_full_unstemmed How to improve hospital admission screening for patients at risk of multidrug-resistant organism carriage: a before-and-after interventional study and cost-effectiveness analysis
title_short How to improve hospital admission screening for patients at risk of multidrug-resistant organism carriage: a before-and-after interventional study and cost-effectiveness analysis
title_sort how to improve hospital admission screening for patients at risk of multidrug-resistant organism carriage: a before-and-after interventional study and cost-effectiveness analysis
topic Quality Improvement Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052048/
https://www.ncbi.nlm.nih.gov/pubmed/35483731
http://dx.doi.org/10.1136/bmjoq-2021-001699
work_keys_str_mv AT joubertdominique howtoimprovehospitaladmissionscreeningforpatientsatriskofmultidrugresistantorganismcarriageabeforeandafterinterventionalstudyandcosteffectivenessanalysis
AT cullatistephane howtoimprovehospitaladmissionscreeningforpatientsatriskofmultidrugresistantorganismcarriageabeforeandafterinterventionalstudyandcosteffectivenessanalysis
AT briotpascal howtoimprovehospitaladmissionscreeningforpatientsatriskofmultidrugresistantorganismcarriageabeforeandafterinterventionalstudyandcosteffectivenessanalysis
AT righilorenzo howtoimprovehospitaladmissionscreeningforpatientsatriskofmultidrugresistantorganismcarriageabeforeandafterinterventionalstudyandcosteffectivenessanalysis
AT grauserdamien howtoimprovehospitaladmissionscreeningforpatientsatriskofmultidrugresistantorganismcarriageabeforeandafterinterventionalstudyandcosteffectivenessanalysis
AT ourahmouneaimad howtoimprovehospitaladmissionscreeningforpatientsatriskofmultidrugresistantorganismcarriageabeforeandafterinterventionalstudyandcosteffectivenessanalysis
AT chopardpierre howtoimprovehospitaladmissionscreeningforpatientsatriskofmultidrugresistantorganismcarriageabeforeandafterinterventionalstudyandcosteffectivenessanalysis